Navigation Links
Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer
Date:5/28/2009

approved indications for Tarceva, OSI's ability to protect its intellectual property rights, safety concerns regarding Tarceva, competition to Tarceva and OSI's drug candidates from other biotechnology and pharmaceutical companies, the completion of clinical trials, the effects of FDA and other governmental regulation, including pricing controls, OSI's ability to successfully develop and commercialize drug candidates, and other factors described in OSI Pharmaceuticals' filings with the Securities and Exchange Commission

(1) El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999;340:745-750

(2) Available at American Society of Clinical Oncology: http://www.asco.org/patient/Cancer+Types/Liver+Cancer.

(3) Ferlay J, et al., GLOBOCAN 2002. Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No.5, Version 2.0. IARCPress, Lyon, 2004. Available at: http://www-dep.iarc.fr.

(4) Ries LAG, Melbert D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Horner MJ, Howlader N, Eisner MP, Reichman M, Edwards BK (eds). SEER Cancer Statistics Review, 1975-2004, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2004/, based on November 2006 SEER data submission, posted to the SEER web site, 2007.


'/>"/>
SOURCE Bayer HealthCare Pharmaceuticals Inc.; OSI Pharmaceuticals; Onyx Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Ceregene Presents Additional Clinical Data from Phase 2 Trial of CERE-120 for Parkinsons Disease
2. The National Association of Boards of Pharmacy (NABP) Moves to Next Phase of Technician Recognition and Regulation
3. MAP Pharmaceuticals Phase 3 Trial of LEVADEX(TM) Migraine Product Candidate Meets All Four Primary Endpoints
4. Bioniche Phase III Clinical Trial with Urocidin(TM) Progressing Well
5. National Medical Interpreter Certification Testing Enters Pilot Phase
6. Results of phase III study on Labopharms novel antidepressant published in Psychiatry (Edgemont) Journal
7. Trubion Pharmaceuticals, Inc. to Present Positive Data From a Phase 2b Re-treatment Study of TRU-015 at the 2009 EULAR Annual Meeting
8. Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Sarcoma and Osteosarcoma: Phase I/II and Phase II Studies, ASCO 2009
9. InDex Pharmaceuticals AB Engages PharmaVentures to Facilitate the Licensing of Kappaproct(R) After Phase IIa Trial Achieves Clinical Endpoints Early
10. BioVex To Announce Updated Survival Data From a Phase II Clinical Study of OncoVEX GM-CSF in Metastatic Melanoma at The 2009 American Society of Clinical Oncology Meeting
11. Kinovate Life Sciences, Inc. and Nitto Denko Corporation Announce Successful Development of NittoPhase™ HL High Loading Solid Support for Oligonucleotide Synthesis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... latest blog post, Best Drug Rehabilitation , which offers ... a stay in rehab can make a big difference in ... 10 tips to help drug or alcohol addicts cope after ... and one that former addicts and those who support them ... Rehabilitation’s CEO Per Wickstrom . , According to ...
(Date:7/31/2014)... Thanks to its mildly sweet flavor ... been used as a medium for delivery of ... However consistent, dependable sourcing of erythritol often fluctuates. ... and beverage manufacturers’ increasing needs for reliable, dependable, ... ErysweetTM Erythritol. , “Erysweet is unique in ...
(Date:7/31/2014)... 2014 Nuanced Media, a leading digital ... the Nuanced Medical website . Nuanced Medical, and ... of the Medical Industry. , The idea behind Nuanced ... medical practices to meet continuously changing federal regulations. The ... Act (Health Insurance Portability and Accountability Act), which is ...
(Date:7/30/2014)... Calling all runners in the Richmond, VA region. , ... a monthly Runner’s Injury Clinic at the Glen ... second Monday of each month through the end of the ... and December 8. , The clinics run from 5:30 ... shoes and attire, will receive a complimentary evaluation of running ...
(Date:7/30/2014)... July 31, 2014 Responding to ... environment more responsive to an increasingly diverse patient ... experience and scholarly expertise to the publication of ... care professions: "Diversity and Cultural Competence in Health ... L. Dreachslin, PhD, a professor in the Management ...
Breaking Medicine News(10 mins):Health News:New Best Drug Rehabilitation Blog Posts Looks at 10 Tips for Coping After Drug or Alcohol Rehab 2Health News:Steviva Ingredients Launches Erysweet Erythritol 2Health News:Nuanced Media, HIPAA Certified Agency, Launches Medical Web Design Service Website 2Health News:Tidewater Physical Therapy to Host Monthly Runner’s Injury Clinic at 3 Sports Glen Allen Location 2Health News:Tidewater Physical Therapy to Host Monthly Runner’s Injury Clinic at 3 Sports Glen Allen Location 3Health News:NLN CEO Co-Authors Textbook to Advance Diversity and Cultural Competence Across Health Care Professions 2Health News:NLN CEO Co-Authors Textbook to Advance Diversity and Cultural Competence Across Health Care Professions 3
... today that it has reached an agreement to sell ... asset-backed commercial paper (ABCP) with,a book value of $7.0 ... right to receive additional proceeds in the event the,buyer ... event, Westaim,will receive 50 per cent of any proceeds ...
... 26 ALLDATA SHREDDING INC., the leading,Pacific Northwest information ... tomorrow. The closely-held,family-owned and operated company commemorates the following ... zero security breaches. -- An overall performance rating ... & Bradstreet,s Open Ratings. ...
... SINGAPORE, Nov. 26 Flextronics (Nasdaq: FLEX ),today ... Tuesday,January 29, 2008., The earnings conference call, hosted ... PST to discuss the financial results,of the Company for ... earnings call will be available via the Internet and ...
... Computed tomography (CT) angiography is as accurate as an ... the findings of the first two prospective multicenter 64-slice ... the Radiological Society of North America (RSNA). , ... stage for the widespread adoption of and reimbursement for ...
... It may be undertreated compared to white patients, research suggests ... more likely than white women to suffer severe pain linked ... more than 1,100 patients in 19 countries. , The women ... were given a pain test called the Brief Pain Inventory ...
... Mich., Nov. 26 In keeping with its,commitment to ... Care Network of Michigan, a leading HMO in the ... among its own employees at the,workplace., BCN, which ... of,Michigan, earlier this year instituted Wellness Works!, an employee ...
Cached Medicine News:Health News:Westaim reduces ABCP exposure 2Health News:ALLDATA SHREDDING Celebrates Fifth Anniversary With 'A' Grade From Clients 2Health News:Flextronics to Report Third Quarter Results 2Health News:CT angiography highly accurate, multicenter trials show 2Health News:Leading by Example: Blue Care Network of Michigan Shows How Employers Can Improve Employee Wellness 2
(Date:7/30/2014)... and NEW YORK , July ... a developer of new products for oncology supportive care, ... ® , has been featured in an article on ... Symptoms in Head and Neck Cancers."  Dr. Steve ... insight on the growing demand seen in the oncology ...
(Date:7/30/2014)... LAKE FOREST, Ill., July 30, 2014  Hospira, ... leading provider of injectable drugs and infusion technologies, ... June 30, 2014. Net sales for the quarter ... share were $0.72. (Adjusted* measures exclude specified items ... the attached schedules.) On a U.S. Generally Accepted ...
(Date:7/30/2014)... DIEGO , July 30, 2014   ... biotech company that designs and develops novel diagnostics ... of cancer, announced today the completion of a ... financing included new investors RusnanoMedInvest (RMI) and Arcus ... and Pfizer Venture Investments, as well as undisclosed ...
Breaking Medicine Technology:Access Pharmaceuticals Featured On OncLive.com 2Access Pharmaceuticals Featured On OncLive.com 3Hospira Reports Second-Quarter 2014 Results 2Hospira Reports Second-Quarter 2014 Results 3Hospira Reports Second-Quarter 2014 Results 4Hospira Reports Second-Quarter 2014 Results 5Hospira Reports Second-Quarter 2014 Results 6Hospira Reports Second-Quarter 2014 Results 7Hospira Reports Second-Quarter 2014 Results 8Hospira Reports Second-Quarter 2014 Results 9Hospira Reports Second-Quarter 2014 Results 10Hospira Reports Second-Quarter 2014 Results 11Hospira Reports Second-Quarter 2014 Results 12Hospira Reports Second-Quarter 2014 Results 13Hospira Reports Second-Quarter 2014 Results 14Hospira Reports Second-Quarter 2014 Results 15Hospira Reports Second-Quarter 2014 Results 16Hospira Reports Second-Quarter 2014 Results 17Hospira Reports Second-Quarter 2014 Results 18Hospira Reports Second-Quarter 2014 Results 19Hospira Reports Second-Quarter 2014 Results 20Hospira Reports Second-Quarter 2014 Results 21Hospira Reports Second-Quarter 2014 Results 22Hospira Reports Second-Quarter 2014 Results 23Hospira Reports Second-Quarter 2014 Results 24Hospira Reports Second-Quarter 2014 Results 25Hospira Reports Second-Quarter 2014 Results 26Hospira Reports Second-Quarter 2014 Results 27Hospira Reports Second-Quarter 2014 Results 28Hospira Reports Second-Quarter 2014 Results 29Hospira Reports Second-Quarter 2014 Results 30Hospira Reports Second-Quarter 2014 Results 31Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine 2Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine 3
... announcement today, the University of California Los Angeles (UCLA) ... report the launch of the CLEAR Study , ... Obstructive Pulmonary Disease (COPD).  COPD is a leading and ... Organization, will become the world,s third most common cause ...
... 6, 2012 HeartWare International, Inc. (NASDAQ: HTWR, ASX:HIN) ... results for the three and 12 months ended December ... on Thursday, February 16, 2012 (being midnight Australian Eastern ... The Company plans to release the financial results prior ...
Cached Medicine Technology:ERT and UCLA Initiate Innovative Pilot Program for Chronically Ill Patients 2ERT and UCLA Initiate Innovative Pilot Program for Chronically Ill Patients 3ERT and UCLA Initiate Innovative Pilot Program for Chronically Ill Patients 4HeartWare Schedules Fourth Quarter Conference Call and Webcast 2
... planned ECCE with peristaltic pump with ... suction, reflux possible with multi-function footswitch ... all critical functions. You can also ... actual vacuum level indicated by Bar ...
... Posterior segment surgeries Vitrectomy-Lensectomy + Irrigation/Aspiration ... Peristaltic Linear Aspiration. Interchangeable disposable blades ... action. Easy to read LED display ... from 1- 600 cuts per minute. ...
...
Enables Delicate Lifting Of The Flap Without Causing Trauma - Also available in Titanium...
Medicine Products: